References
- Denninghoff KR, Nuno T, Pauls Q, Yeatts SD, Silbergleit R, Palesch YY, Merck LH, Manley GT, Wright DW. Prehospital intubation is associated with favorable outcomes and lower mortality in ProTECT III. Prehosp Emerg Care. 2017;21:539–44. doi:10.1080/10903127.2017.1315201. Cited in PubMed; PMID:28489506.
- Wright EW, Yeatts SD, Silbergleit R, Palesch YY, Hertzberg VS, Frankel M, et al. Very early administration of progesterone for acute traumatic brain injury. New Engl J Med. 2014;371:2457–66. doi:10.1056/NEJMoa1404304. Cited in PubMed; PMID:25493974.
- Lafferty KA, Schraga ED, Windle ML, Dillinger R. Medications for rapid sequence endotracheal intubation. Medscape, Drugs & Diseases, Clinical Procedures. Updated Jun 20 2017. [cited 2017 Oct 20]. Available from: https://emedicine.medscape.com/article/109739-overview#a1. Accessed October 20, 2017.
- Howard RB, Sayeed I, Stein DG. Suboptimal dosing parameters as possible factors in the negative Phase III clinical trials of progesterone in TBI. J Neurotrauma. 2017;34:1915–18. doi:10.1089/neu.2015.4179. Cited in PubMed; PMID:26370183.
- Stein DG. Embracing failure: what the Phase III progesterone studies can teach about TBI clinical trials. Brain Inj. 2015;29:1259–72. doi:10.3109/02699052.2015.1065344. Cited in PubMed; PMID:26274493.